EMA vs EMACO in the treatment of gestational trophoblastic neoplasia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EMA vs EMACO in the treatment of gestational trophoblastic neoplasia

Published:2020-07 Issue:1 Volume:158 Page:99-104
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Jareemit Nida,Horowitz Neil S.,Goldstein Donald P.,Berkowitz Ross S.,Elias Kevin M.

Funder

Donald P. Goldstein, M.D., Trophoblastic Tumor Registry Endowment

Dyett Family Trophoblastic Disease Research and Registry Endowment

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference30 articles.

1. Gestational trophoblastic neoplasia management: an update;Ngan;Curr. Opin. Oncol.,2007

2. Choriocarcinoma incidence in the United States;Brinton;Am. J. Epidemiol.,1986

3. Current management of gestational trophoblastic diseases;Berkowitz;Gynecol. Oncol.,2009

4. Update on the diagnosis and management of gestational trophoblastic disease;Ngan;Int. J. Gynaecol. Obstet.,2018

5. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment;Kohorn;Int. J. Gynecol. Cancer,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of trophoblastic tumors : review of evidence, current practice, and future directions;Expert Review of Anticancer Therapy;2023-05-22

2. Treatments and outcomes in high‐risk gestational trophoblastic neoplasia: A systematic review and meta‐analysis;BJOG: An International Journal of Obstetrics & Gynaecology;2023-01-25

3. Gestational trophoblastic disease;Diagnosis and Treatment of Rare Gynecologic Cancers;2023

4. Current chemotherapeutic options for the treatment of gestational trophoblastic disease;Expert Opinion on Pharmacotherapy;2022-11-27

5. Risk Factors That Correlate with Resistance to First-Line Chemotherapy on High-risk Gestational Trophoblastic Neoplasia;Open Access Macedonian Journal of Medical Sciences;2022-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3